Loading company…
California-based Singular Bio develops a single-molecule testing platform for diagnostics in personalized medicine.
Founded in 2012 and based in California, US, Singular Bio, Inc. develops a testing platform for diagnostics in personalized medicine. The technology provides single-molecule analysis of a patient's DNA. Its listed funding stage is Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in